Home › Ovarian Epithelial Carcinoma › Michigan › Detroit
Ovarian Epithelial Carcinoma clinical trials in Detroit, MI
3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
RecruitingPhase 3
- Karmanos Cancer Institute, Detroit
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
RecruitingPhase 3
- Research Site, Detroit
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
RecruitingPhase 1
- Karmanos Cancer Institute, Detroit
Ovarian Epithelial Carcinoma trials in other cities
- New York City, NY10 studies
- Boston, MA8 studies
- Durham, NC8 studies
- Cleveland, OH7 studies
- Houston, TX7 studies
- Baltimore, MD6 studies
- Chicago, IL6 studies
- Philadelphia, PA6 studies
- Salt Lake City, UT6 studies
- Edison, NJ5 studies
- Los Angeles, CA5 studies
- Minneapolis, MN5 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer40 studies
- Breast Cancer34 studies
- Ovarian Cancer28 studies
- Cancer (all types)27 studies
- Colorectal Cancer25 studies
- Prostate Cancer23 studies
- Endometrial Cancer23 studies
- Metastatic Cancer22 studies
- Lung Cancer19 studies
- Multiple Myeloma19 studies
- Head and Neck Squamous Cell Carcinoma16 studies
- Stomach Cancer15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.